Ionis Pharmaceuticals moves forward with FDA review of donidalorsen for HAE
In a significant development for hereditary angioedema (HAE) patients, Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced that the U.S. Food and Drug Administration (FDA) has accepted ... Read More
Exicure’s stock explodes 78% overnight – but is the comeback for real?
Shares of biopharmaceutical company Exicure Inc. skyrocketed by 78% in after-hours trading, closing at $2.84. The surge came after Exicure announced a significant debt-for-equity exchange ... Read More
Convenience store giant Alimentation Couche-Tard to snap up GetGo Café + Market in mega deal
Alimentation Couche-Tard Inc. has announced a significant move in the convenience retail sector with its acquisition of GetGo Café + Market stores from Giant Eagle ... Read More
How PETRONAS, Enilive, and Euglena’s biorefinery in Malaysia could redefine global energy markets
Petroliam Nasional Berhad (PETRONAS), Enilive S.p.A, and Euglena Co., Ltd. have reached a major milestone with their final investment decision (FID) to develop a cutting-edge ... Read More
InventisBio licenses lung cancer drug D-0316 to Betta Pharma in RMB230m deal
In a significant development within the pharmaceutical industry, Shanghai-based InventisBio has entered into a strategic partnership with Betta Pharmaceuticals Co., Ltd. to co-develop the promising ... Read More